ETFs with ABT as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.78%||iShares U.S. Pharmaceutical ETF (IHE)||+12.07 (11.59%)|
|4.04%||Vanguard Dividend Appreciation ETF (VIG)||+4.07 (5.90%)|
|3.21%||WisdomTree Low P/E Fund (EZY)||+5.22 (10.34%)|
|2.52%||Vanguard Health Care ETF (VHT)||+9.49 (10.47%)|
|1.76%||Columbia Large Cap Growth ETF (RPX)||+6.76 (20.66%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products. FINANCIAL INFORMATION RELATING TO INDUSTRY SEGMENTS, GEOGRAPHIC AREAS, AND CLASSES OF SIMILAR PRODUCTS Incorporated herein by reference is Note 6 entitled "Segment and Geographic Area Information" of the Notes to Consolidated Financial Statements included under Item 8, "Financial Statements and Supplementary Data" and the sales information related to HUMIRA® included in "Financial Review." NARRATIVE DESCRIPTION OF BUSINESS Through December 31, 2012, Abbott had five reportable revenue segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. ... More ...